.

Novavax Covid Jab Highly Effective, But Not Against South Africa Variant

US biotech firm Novavax said Thursday its two-shot Covid-19 vaccine showed an overall efficacy of 89.3 percent in a major Phase 3 clinical trial in Britain, and remained highly effective against a...

from NDTV News - World-news https://ift.tt/36lyTbO

Resent New

Discord abandons Microsoft acquisition talks: Report

Discussion platform Discord, popular among amateur video game players, has halted acquisition talks with Microsoft and is instead considerin...

Most popular News